Able Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Buy
2,109
+207
+11% +$23.9K 0.06% 123
2025
Q4
$200K Buy
+1,902
New +$179K 0.06% 113
2025
Q1
Sell
-2,014
Closed -$200K 104
2024
Q4
$200K Buy
2,014
+68
+3% +$7.01K 0.13% 96
2024
Q3
$221K Hold
1,946
0.17% 84
2024
Q2
$241K Buy
1,946
+11
+0.6% +$1.42K 0.2% 73
2024
Q1
$255K Sell
1,935
-10
-0.5% -$1.23K 0.22% 70
2023
Q4
$212K Buy
+1,945
New +$202K 0.19% 73

Other funds holding MRK

Able Wealth Management's MRK Position: Q1 2026 in Review

Able Wealth Management increased its Merck (MRK) stake by 11% in Q1 2026, buying an estimated $23.9K and bringing the position to 2,109 shares worth $211K. The position accounts for 0.06% of the portfolio, ranked #123.

Able Wealth Management first reported a position in MRK in Q4 2023 and has held it in 7 quarters since. The position peaked at $255K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Able Wealth Management held 2,109 shares of Merck worth $211K as of Q1 2026.
  • Able Wealth Management bought 207 Merck shares in Q1 2026, an estimated $23.9K.
  • Merck made up 0.06% of Able Wealth Management's portfolio in Q1 2026, its #123 holding.
  • Able Wealth Management first reported a position in Merck in Q4 2023 and has held it in 7 quarters since.
  • Able Wealth Management's Merck position peaked at $255K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Able Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.